CA2806625A1 - Cellules souches embryonnaires isolees exprimant des marqueurs de lignee et methodes connexes - Google Patents

Cellules souches embryonnaires isolees exprimant des marqueurs de lignee et methodes connexes Download PDF

Info

Publication number: CA2806625A1
Authority: CA; Canada
Prior art keywords: esc; escs; cells; express; kit
Prior art date: 2011-06-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2806625A

Other languages

English (en)

Inventor

Mickie Bhatia

Seok-Ho Hong

Jungbok Lee

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

McMaster University

Original Assignee

McMaster University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-06-14

Filing date

2012-06-14

Publication date

2012-12-20

2012-06-14 Application filed by McMaster University filed Critical McMaster University

2012-12-20 Publication of CA2806625A1 publication Critical patent/CA2806625A1/fr

Status Abandoned legal-status Critical Current

Links

210000001671 embryonic stem cell Anatomy 0.000 title claims abstract description 307
238000000034 method Methods 0.000 title claims abstract description 130
210000004027 cell Anatomy 0.000 claims abstract description 317
230000004069 differentiation Effects 0.000 claims abstract description 135
210000000130 stem cell Anatomy 0.000 claims abstract description 121
230000014509 gene expression Effects 0.000 claims abstract description 103
230000001537 neural effect Effects 0.000 claims abstract description 99
239000001963 growth medium Substances 0.000 claims abstract description 35
230000000694 effects Effects 0.000 claims abstract description 11
230000003394 haemopoietic effect Effects 0.000 claims description 62
238000012360 testing method Methods 0.000 claims description 31
101710150336 Protein Rex Proteins 0.000 claims description 25
108010051779 histone H3 trimethyl Lys4 Proteins 0.000 claims description 25
101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 claims description 23
230000001965 increasing effect Effects 0.000 claims description 21
210000003958 hematopoietic stem cell Anatomy 0.000 claims description 18
101150081664 PAX6 gene Proteins 0.000 claims description 16
238000012258 culturing Methods 0.000 claims description 16
238000001943 fluorescence-activated cell sorting Methods 0.000 claims description 16
102100024208 Homeobox protein MIXL1 Human genes 0.000 claims description 15
101001052462 Homo sapiens Homeobox protein MIXL1 Proteins 0.000 claims description 15
102000008730 Nestin Human genes 0.000 claims description 15
108010088225 Nestin Proteins 0.000 claims description 15
102000007354 PAX6 Transcription Factor Human genes 0.000 claims description 15
230000011987 methylation Effects 0.000 claims description 15
238000007069 methylation reaction Methods 0.000 claims description 15
210000005055 nestin Anatomy 0.000 claims description 15
108010062847 neurofilament protein NF 68 Proteins 0.000 claims description 15
210000004498 neuroglial cell Anatomy 0.000 claims description 13
210000003061 neural cell Anatomy 0.000 claims description 10
210000002569 neuron Anatomy 0.000 claims description 10
239000002243 precursor Substances 0.000 claims description 10
-1 Meox1 Proteins 0.000 claims description 9
230000003319 supportive effect Effects 0.000 claims description 9
101100163882 Mus musculus Ascl1 gene Proteins 0.000 claims description 8
101100310657 Mus musculus Sox1 gene Proteins 0.000 claims description 8
101100445364 Mus musculus Eomes gene Proteins 0.000 claims description 7
101100445365 Xenopus laevis eomes gene Proteins 0.000 claims description 7
210000001130 astrocyte Anatomy 0.000 claims description 7
210000004248 oligodendroglia Anatomy 0.000 claims description 6
238000012216 screening Methods 0.000 claims description 4
239000003550 marker Substances 0.000 abstract description 24
102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 61
101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 61
210000002242 embryoid body Anatomy 0.000 description 44
108090000623 proteins and genes Proteins 0.000 description 43
238000004458 analytical method Methods 0.000 description 24
108010033040 Histones Proteins 0.000 description 21
238000002487 chromatin immunoprecipitation Methods 0.000 description 21
238000003556 assay Methods 0.000 description 20
210000001778 pluripotent stem cell Anatomy 0.000 description 20
238000000684 flow cytometry Methods 0.000 description 19
239000002609 medium Substances 0.000 description 19
230000003021 clonogenic effect Effects 0.000 description 18
230000004048 modification Effects 0.000 description 18
238000012986 modification Methods 0.000 description 18
241000699666 Mus <mouse, genus> Species 0.000 description 17
108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 17
102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 17
230000001413 cellular effect Effects 0.000 description 17
239000000203 mixture Substances 0.000 description 16
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 15
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 15
238000010186 staining Methods 0.000 description 15
238000011161 development Methods 0.000 description 11
230000018109 developmental process Effects 0.000 description 11
238000002474 experimental method Methods 0.000 description 11
230000002441 reversible effect Effects 0.000 description 11
238000011282 treatment Methods 0.000 description 11
241000283707 Capra Species 0.000 description 10
108010077544 Chromatin Proteins 0.000 description 10
108060005980 Collagenase Proteins 0.000 description 10
102000029816 Collagenase Human genes 0.000 description 10
230000004913 activation Effects 0.000 description 10
210000003483 chromatin Anatomy 0.000 description 10
229960002424 collagenase Drugs 0.000 description 10
210000003716 mesoderm Anatomy 0.000 description 10
101000883014 Homo sapiens Protein capicua homolog Proteins 0.000 description 9
102100038777 Protein capicua homolog Human genes 0.000 description 9
238000004113 cell culture Methods 0.000 description 8
210000002950 fibroblast Anatomy 0.000 description 8
239000012634 fragment Substances 0.000 description 8
230000012010 growth Effects 0.000 description 8
210000000601 blood cell Anatomy 0.000 description 7
230000024245 cell differentiation Effects 0.000 description 7
238000002955 isolation Methods 0.000 description 7
230000000877 morphologic effect Effects 0.000 description 7
230000035755 proliferation Effects 0.000 description 7
230000004075 alteration Effects 0.000 description 6
230000027455 binding Effects 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
108010082117 matrigel Proteins 0.000 description 6
102000004169 proteins and genes Human genes 0.000 description 6
230000035899 viability Effects 0.000 description 6
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
239000000872 buffer Substances 0.000 description 5
239000006285 cell suspension Substances 0.000 description 5
238000009643 clonogenic assay Methods 0.000 description 5
231100000096 clonogenic assay Toxicity 0.000 description 5
230000007423 decrease Effects 0.000 description 5
238000010494 dissociation reaction Methods 0.000 description 5
230000005593 dissociations Effects 0.000 description 5
238000009472 formulation Methods 0.000 description 5
230000001976 improved effect Effects 0.000 description 5
238000001727 in vivo Methods 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
229920000609 methyl cellulose Polymers 0.000 description 5
239000001923 methylcellulose Substances 0.000 description 5
239000012071 phase Substances 0.000 description 5
239000000047 product Substances 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
238000000926 separation method Methods 0.000 description 5
230000004083 survival effect Effects 0.000 description 5
YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 4
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
101000843569 Homo sapiens Transcription factor HES-3 Proteins 0.000 description 4
108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
102000009664 Microtubule-Associated Proteins Human genes 0.000 description 4
108010020004 Microtubule-Associated Proteins Proteins 0.000 description 4
238000001190 Q-PCR Methods 0.000 description 4
238000011529 RT qPCR Methods 0.000 description 4
102100030773 Transcription factor HES-3 Human genes 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
230000008859 change Effects 0.000 description 4
230000001332 colony forming effect Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
230000001973 epigenetic effect Effects 0.000 description 4
238000012423 maintenance Methods 0.000 description 4
238000010899 nucleation Methods 0.000 description 4
230000037452 priming Effects 0.000 description 4
238000011002 quantification Methods 0.000 description 4
238000003757 reverse transcription PCR Methods 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
108700012813 7-aminoactinomycin D Proteins 0.000 description 3
108090000695 Cytokines Proteins 0.000 description 3
102000004127 Cytokines Human genes 0.000 description 3
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
102100037362 Fibronectin Human genes 0.000 description 3
108010067306 Fibronectins Proteins 0.000 description 3
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
108010002386 Interleukin-3 Proteins 0.000 description 3
102100020880 Kit ligand Human genes 0.000 description 3
101150059272 TBX6 gene Proteins 0.000 description 3
102000040945 Transcription factor Human genes 0.000 description 3
108091023040 Transcription factor Proteins 0.000 description 3
230000003213 activating effect Effects 0.000 description 3
238000004220 aggregation Methods 0.000 description 3
239000011324 bead Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
230000030833 cell death Effects 0.000 description 3
230000003915 cell function Effects 0.000 description 3
230000004663 cell proliferation Effects 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
210000001654 germ layer Anatomy 0.000 description 3
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
238000003384 imaging method Methods 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
210000001161 mammalian embryo Anatomy 0.000 description 3
239000000463 material Substances 0.000 description 3
238000007747 plating Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000004445 quantitative analysis Methods 0.000 description 3
238000011536 re-plating Methods 0.000 description 3
230000009467 reduction Effects 0.000 description 3
239000011435 rock Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
238000004114 suspension culture Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 2
101100069853 Caenorhabditis elegans hil-3 gene Proteins 0.000 description 2
108020004414 DNA Proteins 0.000 description 2
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
238000010867 Hoechst staining Methods 0.000 description 2
101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 2
102100039064 Interleukin-3 Human genes 0.000 description 2
101710087603 Mast/stem cell growth factor receptor Kit Proteins 0.000 description 2
238000000692 Student's t-test Methods 0.000 description 2
206010043276 Teratoma Diseases 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
239000006143 cell culture medium Substances 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000004186 co-expression Effects 0.000 description 2
238000010293 colony formation assay Methods 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
210000004748 cultured cell Anatomy 0.000 description 2
230000001186 cumulative effect Effects 0.000 description 2
238000010586 diagram Methods 0.000 description 2
239000000539 dimer Substances 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000000975 dye Substances 0.000 description 2
210000003981 ectoderm Anatomy 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000010195 expression analysis Methods 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
230000004077 genetic alteration Effects 0.000 description 2
231100000118 genetic alteration Toxicity 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
238000003364 immunohistochemistry Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000010212 intracellular staining Methods 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
210000002540 macrophage Anatomy 0.000 description 2
238000005259 measurement Methods 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
239000011859 microparticle Substances 0.000 description 2
230000004660 morphological change Effects 0.000 description 2
210000004940 nucleus Anatomy 0.000 description 2
239000008188 pellet Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000001172 regenerating effect Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
238000009256 replacement therapy Methods 0.000 description 2
230000001718 repressive effect Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000013589 supplement Substances 0.000 description 2
230000002459 sustained effect Effects 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
230000003442 weekly effect Effects 0.000 description 2
BUOYTFVLNZIELF-UHFFFAOYSA-N 2-phenyl-1h-indole-4,6-dicarboximidamide Chemical compound N1C2=CC(C(=N)N)=CC(C(N)=N)=C2C=C1C1=CC=CC=C1 BUOYTFVLNZIELF-UHFFFAOYSA-N 0.000 description 1
101800000263 Acidic protein Proteins 0.000 description 1
108090000672 Annexin A5 Proteins 0.000 description 1
102000004121 Annexin A5 Human genes 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
102100032528 C-type lectin domain family 11 member A Human genes 0.000 description 1
101710167766 C-type lectin domain family 11 member A Proteins 0.000 description 1
101100338243 Caenorhabditis elegans hil-6 gene Proteins 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
108700029231 Developmental Genes Proteins 0.000 description 1
101100477411 Dictyostelium discoideum set1 gene Proteins 0.000 description 1
206010013710 Drug interaction Diseases 0.000 description 1
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
102000053171 Glial Fibrillary Acidic Human genes 0.000 description 1
101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
102000004889 Interleukin-6 Human genes 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
102000019149 MAP kinase activity proteins Human genes 0.000 description 1
108040008097 MAP kinase activity proteins Proteins 0.000 description 1
208000003263 MASS syndrome Diseases 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
101150012532 NANOG gene Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
239000012807 PCR reagent Substances 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
238000012356 Product development Methods 0.000 description 1
239000004365 Protease Substances 0.000 description 1
101000713578 Rattus norvegicus Tubulin beta-3 chain Proteins 0.000 description 1
238000010818 SYBR green PCR Master Mix Methods 0.000 description 1
241000862969 Stella Species 0.000 description 1
108010039445 Stem Cell Factor Proteins 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
108010076089 accutase Proteins 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
210000004504 adult stem cell Anatomy 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
238000003491 array Methods 0.000 description 1
101150036080 at gene Proteins 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
210000003651 basophil Anatomy 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000011616 biotin Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
210000002459 blastocyst Anatomy 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000033081 cell fate specification Effects 0.000 description 1
238000002659 cell therapy Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
230000005757 colony formation Effects 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
238000010226 confocal imaging Methods 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000002247 constant time method Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
210000004207 dermis Anatomy 0.000 description 1
238000001514 detection method Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
238000000295 emission spectrum Methods 0.000 description 1
210000001900 endoderm Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
210000003979 eosinophil Anatomy 0.000 description 1
210000002336 epiblast cell Anatomy 0.000 description 1
230000035612 epigenetic expression Effects 0.000 description 1
230000007608 epigenetic mechanism Effects 0.000 description 1
230000004049 epigenetic modification Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
230000000925 erythroid effect Effects 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
238000002073 fluorescence micrograph Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
230000002518 glial effect Effects 0.000 description 1
210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
239000001046 green dye Substances 0.000 description 1
230000005283 ground state Effects 0.000 description 1
230000036433 growing body Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
238000012760 immunocytochemical staining Methods 0.000 description 1
238000003365 immunocytochemistry Methods 0.000 description 1
238000010185 immunofluorescence analysis Methods 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000003116 impacting effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000012933 kinetic analysis Methods 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000011177 media preparation Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
239000013028 medium composition Substances 0.000 description 1
210000003593 megakaryocyte Anatomy 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
238000010197 meta-analysis Methods 0.000 description 1
238000002493 microarray Methods 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000001665 muscle stem cell Anatomy 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
230000003988 neural development Effects 0.000 description 1
210000001178 neural stem cell Anatomy 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
238000012758 nuclear staining Methods 0.000 description 1
238000005457 optimization Methods 0.000 description 1
238000004091 panning Methods 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
230000037361 pathway Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
230000008823 permeabilization Effects 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
239000001397 quillaja saponaria molina bark Substances 0.000 description 1
238000003753 real-time PCR Methods 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
238000013341 scale-up Methods 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
230000023895 stem cell maintenance Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
210000000242 supportive cell Anatomy 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
230000002792 vascular Effects 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Developmental Biology & Embryology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Gynecology & Obstetrics (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Reproductive Health (AREA)
Microbiology (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA2806625A 2011-06-14 2012-06-14 Cellules souches embryonnaires isolees exprimant des marqueurs de lignee et methodes connexes Abandoned CA2806625A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201161496782P	2011-06-14	2011-06-14
US61/496,782		2011-06-14
PCT/CA2012/000592 WO2012171112A1 (fr)	2011-06-14	2012-06-14	Cellules souches embryonnaires isolées exprimant des marqueurs de lignée et méthodes connexes

Publications (1)

Publication Number	Publication Date
CA2806625A1 true CA2806625A1 (fr)	2012-12-20

Family

ID=47356460

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2806625A Abandoned CA2806625A1 (fr)	2011-06-14	2012-06-14	Cellules souches embryonnaires isolees exprimant des marqueurs de lignee et methodes connexes

Country Status (2)

Country	Link
CA (1)	CA2806625A1 (fr)
WO (1)	WO2012171112A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201310354D0 (en) *	2013-06-11	2013-07-24	Ge Healthcare Uk Ltd	Method for cell differentiation
AU2019265019B2 (en)	2018-05-11	2025-11-06	Beam Therapeutics Inc.	Methods of substituting pathogenic amino acids using programmable base editor systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100196923A1 (en) *	2007-08-14	2010-08-05	Anthony Atala	Pluripotent adult stem cells
EP2294185A2 (fr) *	2008-05-08	2011-03-16	Coretherapix Slu	Population de cellules souches adultes multipotentes

2012
- 2012-06-14 CA CA2806625A patent/CA2806625A1/fr not_active Abandoned
- 2012-06-14 WO PCT/CA2012/000592 patent/WO2012171112A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2012171112A1 (fr)	2012-12-20

Legal Events

Date	Code	Title	Description
2013-03-12	EEER	Examination request	Effective date: 20130125
2015-04-14	FZDE	Discontinued	Effective date: 20150217

Publication	Publication Date	Title
US12545891B2 (en)	2026-02-10	Methods for neural conversion of human embryonic stem cells
JP5721111B2 (ja)	2015-05-20	幹細胞の培地及び培養方法
Hong et al.	2011	Cell fate potential of human pluripotent stem cells is encoded by histone modifications
CA2770753C (fr)	2019-01-15	Procede d'induction d'une differenciation de cellules souches pluripotentes en cellules precurseurs neurales
Peh et al.	2009	CD133 expression by neural progenitors derived from human embryonic stem cells and its use for their prospective isolation
JP2017504311A (ja)	2017-02-09	網膜色素上皮細胞を生成する方法
JP2013507135A (ja)	2013-03-04	幹細胞を分化させるための重量オスモル濃度の操作法
JP2012228263A (ja)	2012-11-22	胚性幹細胞のフィーダー非依存性長期培養
Park et al.	2013	Comparison of human first and third trimester placental mesenchymal stem cell
CA2875858C (fr)	2022-05-03	Procedes bases sur la "signature adhesive" destines a isoler des cellules souches et des cellules derivees de celles-ci
US20170349883A1 (en)	2017-12-07	Mature cardiac muscle cell marker
CA2806625A1 (fr)	2012-12-20	Cellules souches embryonnaires isolees exprimant des marqueurs de lignee et methodes connexes
KR20230113768A (ko)	2023-08-01	유도 줄기 세포
Pan et al.	2016	SOX2, OCT3/4 and NANOG expression and cellular plasticity in rare human somatic cells requires CD73
Kandasamy et al.	2017	Glycoconjugates reveal diversity of human neural stem cells (hNSCs) derived from human induced pluripotent stem cells (hiPSCs)
JP2018011527A (ja)	2018-01-25	視床下部前駆細胞の精製方法及びその利用
WO2020044047A1 (fr)	2020-03-05	Milieu de culture
Riebeling et al.	2011	Defined culture medium for stem cell differentiation: applicability of serum-free conditions in the mouse embryonic stem cell test
US20100129910A1 (en)	2010-05-27	Cell matrix related compositions and their use for generating embryoid bodies
Jackson et al.	2007	Techniques for neural differentiation of human EC and ES cells
Santos	2013	Culture Platform for Induction of Human Induced Pluripotent Stem Cells into Cortical Neural Stem and Progenitor Cells under Chemically Defined Conditions
Sugawa	2014	Generation and molecular analysis of in vitro germ cells from mouse and human pluripotent stem cells
Young-Eun et al.	2011	Comparative analysis for in vitro differentiation potential of induced pluripotent stem cells, embryonic stem cells, and multipotent spermatogonial stem cells into germ-lineage cells
Draper et al.	2007	Phenotypic analysis of human embryonic stem cells
Wilcox	2008	Establishment of canine embryonic stem cell lines and production of neural derivatives